Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

584 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality indicators in psoriatic arthritis.
Kavanaugh A, Ritchlin C, Boehncke WH. Kavanaugh A, et al. Clin Exp Rheumatol. 2007 Nov-Dec;25(6 Suppl 47):98-101. Clin Exp Rheumatol. 2007. PMID: 18021513
Defining remission in psoriatic arthritis.
Kavanaugh A, Fransen J. Kavanaugh A, et al. Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-83-7. Clin Exp Rheumatol. 2006. PMID: 17083768 Review.
Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.
Coates LC, Gladman DD, Nash P, FitzGerald O, Kavanaugh A, Kvien TK, Gossec L, Strand V, Rasouliyan L, Pricop L, Ding K, Jugl SM, Gaillez C; FUTURE 2 study group. Coates LC, et al. Among authors: kavanaugh a. Arthritis Res Ther. 2018 Dec 7;20(1):272. doi: 10.1186/s13075-018-1773-y. Arthritis Res Ther. 2018. PMID: 30526678 Free PMC article. Clinical Trial.
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.
Kavanaugh A, Krueger GG, Beutler A, Guzzo C, Zhou B, Dooley LT, Mease PJ, Gladman DD, de Vlam K, Geusens PP, Birbara C, Halter DG, Antoni C; IMPACT 2 Study Group. Kavanaugh A, et al. Ann Rheum Dis. 2007 Apr;66(4):498-505. doi: 10.1136/ard.2006.058339. Epub 2006 Nov 17. Ann Rheum Dis. 2007. PMID: 17114188 Free PMC article. Clinical Trial.
584 results